A carregar...
Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study
Vilazodone is a selective serotonin reuptake inhibitor and a 5-HT(1A) receptor partial agonist that is approved for treatment of major depressive disorder in adults in the USA and Mexico. The efficacy, safety, and tolerability of vilazodone for generalized anxiety disorder (GAD) were investigated in...
Na minha lista:
| Publicado no: | Int Clin Psychopharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams And Wilkins
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4593467/ https://ncbi.nlm.nih.gov/pubmed/26291335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000096 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|